CaReSR-1S

· Arthro-Anda Tianjin Biologic Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CaReSR-1S, covering 2017-10-12 to 2017-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Study on Efficacy and Safety of CaReSR-1S to Repair Cartilage Defects of the Knee [NA]